Search - tctmd.com

Displaying 801 - 820 of 904

Sort: Relevancy | Date

News Daily News

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

January 01, 2014

News Daily News

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

January 01, 2014

News Daily News

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

Yael L. Maxwell

December 08, 2013

News Daily News

SCAI Proposes New Definition for Periprocedural MI

November 01, 2013

News Daily News

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

Caitlin E. Cox

November 01, 2013

News Daily News

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Caitlin E. Cox

October 11, 2013

News Daily News

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

L.A. McKeown

September 20, 2013

News Conference News ESC 2013

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

Caitlin E. Cox

September 03, 2013

News Conference News ESC 2013

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

Caitlin E. Cox

September 01, 2013

News Daily News

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Yael L. Maxwell

August 23, 2013

News Daily News

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Yael L. Maxwell

August 19, 2013

News Daily News

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

Yael L. Maxwell

August 05, 2013

News Daily News

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

July 25, 2013

News Daily News

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

July 25, 2013

News Daily News

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

July 24, 2013

News Daily News

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

July 24, 2013

Presentation

Elderly Patients with ACS Managed Without Revascularization

Presenter: Matthew T. Roe

July 22, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Daily News

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

L.A. McKeown

June 20, 2013

News Conference News EuroPCR 2013

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Caitlin E. Cox

May 24, 2013

Advertisement

Studies Explore How, When Radial PCI Benefits ACS/STEMI Patients

Meta-analysis: Newer-Generation DES Safe, Effective vs. BMS in STEMI

Meta-analysis: PCI Adds No Benefit to Medical Therapy in Patients with Proven Ischemia

SCAI Proposes New Definition for Periprocedural MI

HORIZONS-AMI: Mortality Reduction with Bivalirudin Only Partially Due to Bleeding

INFUSE-AMI: Thirty-Day Reduction in Infarct Size May Translate to 1-Year Benefit

Analysis Strengthens Support for Enoxaparin Over Heparin in PCI for STEMI

BIC-8: Positive Signs for Early-Rule Out of Suspected ACS Using Copeptin

PRAMI: Strong Showing for Complete Revascularization in Acute STEMI Patients

TRILOGY ACS Substudy: Prasugrel Post-Angiography Minimizes Risk of Adverse Events

Upstream Eptifibatide Treatment Linked with Better Outcomes in PCI Patients

Swedish, Canadian Registries: Women Less Likely to Be Reperfused After STEMI

In Older ACS Patients, Half-Dose Prasugrel as Safe as Clopidogrel But No More Effective

En Pacientes Ancianos, Media Dosis de Prasugrel es igual de Segura que el Clopidogrel aunque No Más Eficaz

More Long-term Cardiac Mortality with First-Generation DES vs. BMS for STEMI

Mayor mortalidad cardíaca a largo plazo con la primera generación de SLF vs. SMD para STEMI

Elderly Patients with ACS Managed Without Revascularization

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Increased Mortality Risk Posed by Shock May Not Affect Long-term Survival

ELISA-3: Early vs. Late Intervention No Different for High-Risk NSTE ACS Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content